Dicoflor Elle Med

Vaginal capsules for the treatment of vaginosis and vaginitis.
 

  • For the maintenance of physiological pH
  • Barrier against vaginal pathogens

 
As a consequence, it promotes the reduction of vaginal infections and atrophy symptoms (burning, itching, fish odour, discharge, pelvic pain, dyspareunia, vaginal dryness, etc..)

 

Indications
Product containing polyacrylic acid, indicated in case of changes in the vaginal tract microflora to restore the balance, especially in particular conditions (menstruation, pregnancy, menopause, antibiotic therapy and hormonal contraception). Dicoflor elle med promotes the reduction of symptoms of vaginal infections caused by bacteria (Gardnerella vaginalis, etc.) and yeast (Candida spp.), and of vaginal atrophy.

 

Therapeutic category

Product for vaginal use.

 

Pack size: 7 vaginal capsules.

Description

Dosage and instruction for use
For the treatment of vaginosis and vaginitis in the acute phase:
1 capsule per day for 7 consecutive days; then 1 capsule each 3 days in the following 3 weeks. Apply the capsule into the vagina, in supine position, in the evening before bedtime. In case of vaginal dryness, wet the capsule with warm water before the application in vagina.
Storage condition
Keep stored in original packaging at room temperature, preferably below 25°C and above 10 °C, in a dry place away from light. The expiry date refers to the product properly stored in the whole package.
Warnings
Do not exceed the recommended dose. Only for vaginal use, do not ingest and avoid contact with eyes. Do not use in case of injury or vaginal ulcers. Wash your hands carefully before and after use. Ask to doctor before use during pregnancy. Do not use in case of allergy to any ingredients. In case of adverse reactions, consult your doctor or pharmacist. Do not use in the case the capsule or the packaging do not result intact. Do not use the product after the expiry date indicated on the package. Keep away from children.

It is a medical device

0476

Carefully read the warnings and instructions for use.

 

Ministerial authorization of 28/01/2019

Additional Information

Composition
Fructooligosaccharides, hydroxypropyl methylcellulose, titanium dioxide, probiotics [Lactobacillus reuteri (RC-14®) and Lactobacillus rhamnosus (GR-1®)]*, microcrystalline cellulose, talc, polyacrylic acid, silicon dioxide.

* Lactobacillus rhamnosus, GR-1® (ATCC 55826) and Lactobacillus reuteri, RC-14® (ATCC 55845): exclusive license CHR Hansen. The mixture contains milk derivatives.